Figure 3.
![Figure 3. Example of a false-positive study. Pretransplantation [18F]FDG-PET scan in a patient with nodular sclerosis HD showed residual [18F]FDG uptake parahilar after radiotherapy (arrow). After HDT/SCT, the patient remained in CR (follow-up, 1464 days). (A) Scan before the start of treatment; (B) scan before transplantation; (C) scan after transplantation.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/102/1/10.1182_blood-2002-12-3842/5/h81334568003.jpeg?Expires=1722694998&Signature=PwwjoiVQlmTGdquoArLG8i4PG-lsrQfjzhZFIhmEGuJYYG01Q-4ehKeXN9kE8qJoEl4O4-E3jmXefC1SnhKyBG5HhiG0pwCs8twQ4IImpSjv84GDuMXIJiuh8GjMF2MEGo5ys9HgyvDYPwnfgB1Yz1z-3wKpqLwCrUv6ulu35wSCLQRqKJPqaMoltORM8GGyswA~PjUMiXpJUlASIoHy5-~OFBa4Ooe3fX3Fq83IMKmFCcyXbRDFMkIlmYmMfOgiJJy8bJoAVQch5hThg2cTITmZaes7o9p9zq3tJ9J6uE41jguBrH6A6sf7S6g-rNh~mg4Xy~ZtEvvc-5pt6cnU-Q__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Example of a false-positive study. Pretransplantation [18F]FDG-PET scan in a patient with nodular sclerosis HD showed residual [18F]FDG uptake parahilar after radiotherapy (arrow). After HDT/SCT, the patient remained in CR (follow-up, 1464 days). (A) Scan before the start of treatment; (B) scan before transplantation; (C) scan after transplantation.
